BXPHF fundamentals
An in-depth look to Botanix Pharmaceuticals Ltd. operating, investing, and financing activities
BXPHF free cash flow for H1 24 is -2.58 M USD. For 2023, BXPHF free cash flow was -8.05 M USD and operating cash flow was -8.04 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM